Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Horizon Provides Assurances That Tepezza Sales Are Set To Soar
Guidance Maintained For 30% Growth In 2022
May 05 2022
•
By
Mandy Jackson
Horizon expects more than 30% Tepezza sales growth in 2022 • Source: Shutterstock
More from New Products
More from Scrip